Previous 10 | Next 10 |
STANS, SWITZERLAND / ACCESSWIRE / October 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous syst...
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5 th - 8 th , 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Fall Harvest - Best...
STANS, SWITZERLAND / ACCESSWIRE / September 30, 2021 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous syste...
STANS, SWITZERLAND / ACCESSWIRE / September 28, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...
STANS, SWITZERLAND / ACCESSWIRE / September 24, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervou...
STANS, SWITZERLAND / ACCESSWIRE / September 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervou...
STANS, SWITZERLAND / ACCESSWIRE / September 8, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous...
Gainers: Sonnet BioTherapeutics (NASDAQ:SONN) +127%. Sonoma Pharmaceuticals (NASDAQ:SNOA) +90%. DLocal (NASDAQ:DLO) +26%. Ensysce Biosciences (NASDAQ:ENSC) +23%. Macy's (NYSE:M) +22%. NLS Pharmaceutics (NASDAQ:NLSP) +21%. China Liberal Education (NASDAQ:CLEU) +19%. AudioEye (NASDAQ:AEYE) +14%...
Trading Penny Stocks in 2021 and 3 Small-Caps to Watch With another day of trading penny stocks comes a new list of potential winners. But, scouting out which small-caps may be worth buying right now can be complicated without the right tools. For this reason, let’s go over some ...
Sonoma Pharmaceuticals (NASDAQ:SNOA) +78% expanded dental care line with a new product for professional Care in the U.S. and a new product for professional and consumer care in Switzerland DLocal (NASDAQ:DLO) +20% on Q2 earnings. NLS Pharmaceutics (NASDAQ:NLSP) +14% after mazin...
News, Short Squeeze, Breakout and More Instantly...
NLS Pharmaceutics Ltd. Company Name:
NLSP Stock Symbol:
NASDAQ Market:
NLS Pharmaceutics Ltd. Website:
2024-07-30 06:58:00 ET 3 Different Market Conditions And How to Profit With Penny Stocks During Understanding how to navigate different market conditions is essential for maximizing profits when trading penny stocks. The dynamic nature of the market means that strategies need to be tail...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.3% to $111.59 on volume of 240,827,673 shares Lipella Pharmaceuticals Inc. (LIPO) rose 122.5% to $0.8992 on volume of 193,926,302 shares PROSHARES TRUST (SQQQ) fell 0.5% to $9.05 on volume of 150,372,371...
The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and focused on advancing Kadimastem's allogeneic cell therapy platform Each of Kadimastem and NLS Pharmaceutics has received commitments of support f...